Primary cutaneous cryptococcosis: A distinct clinical entity

被引:157
作者
Neuville, S
Dromer, F
Morin, O
Dupont, B
Ronin, O
Lortholary, O
机构
[1] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycoses & Antifong, F-75724 Paris 15, France
[2] Hop Necker Enfants Malad, Serv Malad Infect & Trop, Paris, France
[3] Hop Hotel Dieu, Lab Parasitol Mycol, Nantes, France
[4] Hop Avicenne, Serv Malad Infect & Trop, F-93009 Bobigny, France
关键词
D O I
10.1086/345956
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcus neoformans is an encapsulated yeast responsible for disseminated meningitis in immunocompromised hosts. Controversies persist on the existence of primary cutaneous cryptococcosis (PCC) versus cutaneous cryptococcosis being only secondary to hematogenous dissemination. Thus, we reviewed cryptococcosis cases associated with skin lesions reported in the French National Registry. Patients with PCC (n = 28) differed significantly from those with secondary cutaneous cryptococcosis (n = 80) or other forms of the disease (n = 1866) by living area (mostly rural), age (older), ratio of men to women (similar to1: 1), and the lack of underlying disease. Evidence of PCC included the absence of dissemination and, predominantly, a solitary skin lesion on unclothed areas presenting as a whitlow or phlegmon, a history of skin injury, participation in outdoor activities, or exposure to bird droppings, and isolation of C. neoformans serotype D. Therefore, PCC is a distinct epidemiological and clinical entity with a favorable prognosis even for immunocompromised hosts.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 104 条
[1]  
ABDEL-FATTAH A, 1975, International Journal of Dermatology, V14, P606, DOI 10.1111/j.1365-4362.1975.tb00149.x
[2]   CRYPTOCOCCAL DISEASE PRESENTING AS CELLULITIS [J].
ANDERSON, DJ ;
SCHMIDT, C ;
GOODMAN, J ;
POMEROY, C .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (03) :666-672
[3]  
ANTONY SA, 1995, CUTIS, V56, P96
[4]   Cutaneous cryptococcosis associated with lepromatous leprosy [J].
Azulay, RD ;
Mendonça, IRM ;
Santos, CM ;
Monteiro, PCF ;
Lazéra, MS ;
Kac, BK ;
Schechtman, RC .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (06) :412-414
[5]   PRIMARY CUTANEOUS CRYPTOCOCCOSIS [J].
BAES, H ;
VANCUTSEM, J .
DERMATOLOGICA, 1985, 171 (05) :357-361
[6]  
Baro T, 1999, J CLIN MICROBIOL, V37, P1170
[7]   A CASE OF PRIMARY CUTANEOUS CRYPTOCOCCOSIS SUCCESSFULLY TREATED WITH MICONAZOLE [J].
BEE, OB ;
TAN, T ;
PANG, R .
ARCHIVES OF DERMATOLOGY, 1981, 117 (05) :290-291
[8]  
Bellosta M, 1999, EUR J DERMATOL, V9, P224
[9]   EPIDEMIOLOGIC DIFFERENCES AMONG SEROTYPES OF CRYPTOCOCCUS-NEOFORMANS [J].
BENNETT, JE ;
KWONCHUNG, KJ ;
HOWARD, DH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (06) :582-586
[10]  
BLANC C, 1979, ANN DERMATOL VENER, V106, P807